Early Stage, HER2-Positive Breast Cancer Patients At Increased Risk Of Recurrence

News — By on December 15, 2008 at 4:00 am

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback